8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

Current Report Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 9, 2012

ART’S-WAY MANUFACTURING CO., INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)
000-05131	42-0920725
(Commission File Number)	(IRS Employer
	Identification No.)
5556 Highway 9 Armstrong, Iowa 50514
(Address of principal executive offices)  (Zip Code)
(712) 864-3131
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On January 3, 2012 and January 6, 2012, Art’s-Way Manufacturing Co., Inc. (the “Company”) issued press releases relating to fourth quarter sales and backlog growth for its wholly-owned subsidiary, Art’s-Way Scientific. The full text of each press release is set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto and is incorporated by reference in this Current Report on Form 8-K as if fully set forth herein.

The information contained in this Item 2.02, including Exhibits 99.1 and 99.2 attached hereto and incorporated herein, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

On January 9, 2012, the Company will present at the Sidoti & Company, LLC Micro-Cap Conference in New York, New York. The event will include a presentation by the Company’s Chairman and Vice-Chairman covering the Company’s historical performance and growth opportunities, as set forth on the slides attached to this Current Report on Form 8-K as Exhibit 99.3. The Company issued a press release on January 9, 2012 to announce the presentation, which is attached to this Current Report on Form 8-K as Exhibit 99.4. The full text of the slides and the press release is incorporated by reference in this Current Report on Form 8-K as if fully set forth herein.

The information contained in this Item 7.01, including Exhibits 99.3 and 99.4 attached hereto and incorporated herein, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 8.01  Other Events.

On January 4, 2012, the Company issued a press release relating to a sales contract procured by its wholly-owned subsidiary, Art’s-Way Scientific. The full text of the  press release is set forth in Exhibit 99.5 attached hereto and is incorporated by reference in this Current Report on Form 8-K as if fully set forth herein.

Item 9.01   Financial Statements and Exhibits.

(a) Financial statements:  None

(b) Pro forma financial information:  None

(c) Shell Company Transactions:  None

(d) Exhibits:

99.1 Press Release dated January 3, 2012

99.2 Press Release dated January 6, 2012

99.3 Slide Presentation used in connection with the Sidoti Micro-Cap Conference on January 9, 2012

99.4 Press Release dated January 9, 2012

99.5 Press Release dated January 4, 2012

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  January 9, 2012

ART’S-WAY MANUFACTURING CO., INC.

/s/ Carrie L. Majeski                                            

Carrie L. Majeski

President, Chief Executive Officer and

Principal Financial Officer

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

ART’S-WAY MANUFACTURING CO., INC.

EXHIBIT INDEX TO FORM 8-K

Date of Report:	Commission File No.:
January 9, 2012	000-05131

Exhibit No.    ITEM

99.1 Press Release dated January 3, 2012

99.2 Press Release dated January 6, 2012

99.3 Slide Presentation used in connection with the Sidoti Micro-Cap Conference on January 9, 2012

99.4 Press Release dated January 9, 2012

99.5 Press Release dated January 4, 2012

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE	For More Information, Contact:
January 3, 2012	Jim Drewitz, Investor Relations 830-669-2466

ART’S WAY MANUFACTURING ANNOUNCES INCREASED SALES

ORDERS FOR ART’S WAY SCIENTIFIC FOR FOURTH QUARTER 2011.

Interest and sales can be attributed to IRS tax incentives on agricultural buildings

ARMSTRONG, Iowa, January 3, 2012 – Art’s Way Manufacturing Co., Inc. (NASDAQ: ARTW), announces its wholly owned subsidiary; Art’s Way Scientific, Inc. www.buildingsforscience.com has experienced an increase in sales orders in the fourth quarter 2011. In addition, Art’s Way Scientific has also seen a meaningful spike in inquiries of modular Ag buildings as a result of Congressional enacted tax incentives on agricultural buildings. Recently the Company received orders for several Ag related buildings, totaling approximately $400,000.

Dan Palmer, General Manager of Art’s Way Scientific said, “Many of these new orders have come from existing customers, and repeat business is always gratifying. The tax incentives will last through 2012 and make it attractive for farmers and ranchers to expand their operations…. so we anticipate the demand to continue through 2012.“

About Art’s Way Scientific, Inc. –Buildings For Science -

Art’s Way Scientific, Inc. is a wholly owned subsidiary of Art’s Way Manufacturing Co., Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers’ critical requirements. For more information, visit our website at www.buildingsforscience.com.

About Art’s Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers. After market service parts are also an important part of the Company's business. We have two wholly owned subsidiaries. Art's Way Vessels, Inc. manufactures pressurized tanks and vessels and Art's Way Scientific, Inc. manufactures modular animal confinement buildings and modular laboratories.

For More Information, Contact:  Jim Drewitz, Investor Relations

830-669-2466

 jim@jdcreativeoptions.com

www.jdcreativeoptions.com

Or visit the Company's website at www.artsway-mfg.com

This news release includes "forward-looking statements" within the meaning of the federal securities laws. Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company's products, domestic and international economic conditions, the management of growth and other risks detailed from time to time in the Company's Securities and Exchange Commission filings. Actual results may differ markedly from management's expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.

-END-

EX-99.2

Exhibit 99.2

FOR IMMEDIATE RELEASE	For More Information, Contact:
January 6, 2012	Jim Drewitz, Investor Relations 830-669-2466

ART’S WAY MANUFACTURING ANNOUNCES RAMPED UP PRODUCTION TO FILL ORDER BACKLOG OF $21.8 MILLION

Backlog For Fiscal Year End In 2012 Is Up 47% Over Fiscal Year 2011

ARMSTRONG, Iowa, January 6, 2012 – Art’s Way Manufacturing Co., Inc. (NASDAQ: ARTW), a leading manufacturer and distributor of agricultural machinery, equipment and services today announces it is ramping up production to fill order backlog of $21.8 million for fiscal year 2012, a 47% increase in backlog over the previous years backlog of $14.8 million.

The growth in backlog is primarily due to the increase orders at Art’s Way Scientific, Inc. www.buildingsforscience.com. The recently announced $7 million order will significantly improve the backlog deep into 2012 along with the increased activity in ag buildings.

J. Ward McConnell, Jr., Executive Chairman of the Board, said, “We are very excited and bullish about our current backlog and growth prospects in 2012. Art’s Way continues to drive on a fundamental strategy to serve our growing customer base with market leading products and service while delivering solid financial performance.  Additionally, Art’s Way Scientific is going to have a record year, the North American agricultural sector is robust, farmers have money and are spending it, our business fundamentals remain exceptionally strong and we believe the Company is well positioned to aggressively move into 2012 and beyond. With little or no operating debt, this will allow the Company to improve cash flow, continue organic growth and pursue select opportunities in the marketplace.”

About Art’s Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers. After market service parts are also an important part of the Company's business. We have two wholly owned subsidiaries. Art's Way Vessels, Inc. manufactures pressurized tanks and vessels and Art's Way Scientific, Inc. manufactures modular animal confinement buildings and modular laboratories.

About Art’s Way Scientific, Inc. –Buildings For Science -

Art’s Way Scientific, Inc. is a wholly owned subsidiary of Art’s Way Manufacturing Co., Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers’ critical requirements. For more information, visit our website at www.buildingsforscience.com.

Investors and shareholders are invited to send their email to jim@jdcreativeoptions.com to be added to the Company’s email database for future news releases.

For More Information, Contact:  Jim Drewitz, Investor Relations

830-669-2466

 jim@jdcreativeoptions.com

www.jdcreativeoptions.com

Or visit the Company's website at www.artsway-mfg.com

This news release includes "forward-looking statements" within the meaning of the federal securities laws. Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company's products, domestic and international economic conditions, the management of growth and other risks detailed from time to time in the Company's Securities and Exchange Commission filings. Actual results may differ markedly from management's expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.

-END-

EX-99.3

Exhibit 99.3

EX-99.5

Exhibit 99.5

FOR IMMEDIATE RELEASE	For More Information, Contact:
JANUARY 4, 2012	Jim Drewitz, Investor Relations 830-669-2466

ART’S WAY MANUFACTURING ANNOUNCES $7 MILLION CONTRACT

FOR A MODULAR BUILDING COMPLEX.

Art’s Way Scientific, Inc., Has Designed and Will Manufacture 24 Modular Units.

ARMSTRONG, Iowa, January 4, 2012 – Art’s Way Manufacturing Co., Inc. (NASDAQ: ARTW), announces its wholly owned subsidiary, Art’s Way Scientific, Inc., www.buildingsforscience.com has designed, and is under contract to manufacture 24 modular units. The modular units are expected to be constructed and installed over the course of approximately one year and will make one 21,350 square foot research facility.  The research facility is being built for one of the world's leading research and teaching institutions.  Art’s Way also expects to procure an installation contract, which could yield additional revenue of approximately $2 million. The anticipated value of the combined contracts would be approximately $9 million over the term of the contracts.

Dan Palmer, President of Art’s Way Scientific said, “We are very pleased…to have the opportunity to produce and complete this critical project”.

Mr. Palmer continued, “Over the last year we have, along with a team of design professionals developed various ideas and concepts for this facility. We signed a design agreement several months ago and the design is complete.  This allowed us to prepare for a quick start on fabrication and site work upon approvals.  Fabrication on the first of the 24 modular sections started recently.  Fabrication and delivery is being coordinated to coincide with completion of the foundation work during the spring and summer months.  The team is targeting occupancy of the building by the end of 2012.”

J. Ward McConnell, Jr., Executive Chairman of the Board, said, “We are excited to be working on this significant project.  I want to thank our hardworking, dedicated employees who have worked tirelessly to bring this contract to fruition. Art’s Way Scientific’s modular laboratories will allow faculty, students and staff to carry out critical research procedures in the buildings.  Our labs will help train students with diverse backgrounds for careers in the biological and biomedical sciences.”

About Art’s Way Scientific, Inc. –Buildings For Science -

Art’s Way Scientific, Inc. is a wholly owned subsidiary of Art’s Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers’ critical requirements. For more information, visit our website at www.buildingsforscience.com.

About Art’s Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers. After market service parts are also an important part of the Company's business. We have two wholly owned subsidiaries. Art's Way Vessels, Inc. manufactures pressurized tanks and vessels and Art's Way Scientific, Inc. manufactures modular animal housing buildings and modular laboratories.

For More Information, Contact:  Jim Drewitz, Investor Relations

830-669-2466

 jim@jdcreativeoptions.com

www.jdcreativeoptions.com

Or visit the Company's website at www.artsway-mfg.com/

This news release includes "forward-looking statements" within the meaning of the federal securities laws. Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company's products, domestic and international economic conditions, the management of growth and other risks detailed from time to time in the Company's Securities and Exchange Commission filings. Actual results may differ markedly from management's expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.

-END-